Printed From:

Register now for savings & support

Here’s what you’ll receive:

SOLIQUA 100/33 $0 CO-PAY
Get your savings card now and pay $0 per prescription for the next 12 months if you're eligible.*

Patient Support
Have a SOLIQUA 100/33 prescription? Sign up for the SOLIQUA 100/33 COACH Program. Get one-on-one calls from a registered nurse, plus customized info and tools at no cost to you.

More Information
Even if you don't have a prescription, you can sign up to learn more about SOLIQUA 100/33 and blood sugar management.

Answer the questions below to begin your registration.

Required fields

See if you qualify for a savings card.

Required fields

Answer YES if any of the following apply:
  • You are 65 years of age or older and neither you nor your spouse are working
  • You are receiving Social Security payments because of a disability
  • You have end-stage renal disease

To register for our COACH Programprogram, please provide your contact information.

†Required Fields

Now, let’s set up your COACH Program phone and messaging preferences.

Let your healthcare professional know how you're doing with Toujeo® COACH

Help us understand what information is right for you.

† Required fields

Registration Authorization

Before submitting your registration, you must click the button below to open and review the Registration Authorization Terms. Once you have finished, check the box below to indicate that that you have read and agree to the terms and then click the “Submit” button at the end of this form to complete your registration.

Click here for Full Prescribing Information for SOLIQUA 100/33.


What is Lantus® (insulin glargine injection) 100 Units/mL?

Prescription Lantus® is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar.

  • Do not use Lantus® to treat diabetic ketoacidosis.
  • Important Safety Information for Lantus® (insulin glargine injection) 100 Units/mL

    Do not take Lantus® during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus®.

    Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.

    Before starting Lantus®, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breast-feeding or planning to breast-feed.

    Heart failure can occur if you are taking insulin together with certain medicines called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you already have heart failure, it may get worse while you take TZDs with Lantus®. Your treatment with TZDs and Lantus® may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms of heart failure, including:

    • Shortness of breath
    • Swelling of your ankles or feet
    • Sudden weight gain

    Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, including herbal supplements.

    Lantus® should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Lantus®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

    Do NOT dilute or mix Lantus® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus® must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.

    While using Lantus®, do not drive or operate heavy machinery until you know how Lantus® affects you. You should not drink alcohol or use other medicines that contain alcohol.

    The most common side effect of insulin, including Lantus®, is low blood sugar (hypoglycemia), which may be serious and life threatening. It may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision.

    Lantus® may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have:

    • A rash over your whole body
    • Trouble breathing
    • A fast heartbeat
    • Sweating
    • Swelling of your face, tongue, or throat
    • Shortness of breath
    • Extreme drowsiness, dizziness, or confusion

    Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions.

    Lantus® SoloSTAR® is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

    Click here for Full Prescribing Information for Lantus®.


    What is Toujeo® (insulin glargine injection) 300 Units/mL?

    Prescription Toujeo® is a long-acting insulin used to control blood sugar in adults with diabetes mellitus.

    • Toujeo® contains 3 times as much insulin in 1 mL as standard insulin (100 Units/mL)
    • Toujeo® is not for use to treat diabetic ketoacidosis
    • Toujeo® should not be used in children

    Important Safety Information for Toujeo® (insulin glargine injection) 300 Units/mL

    Do not take Toujeo® if you have low blood sugar or if you are allergic to insulin or any of the ingredients in Toujeo®.

    Do NOT reuse needles or share insulin pens even if the needle has been changed.

    Before starting Toujeo®, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breastfeeding or planning to breastfeed.

    Heart failure can occur if you are taking insulin together with certain medicines called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Toujeo®. Your treatment with TZDs and Toujeo® may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms of heart failure, including:

    • Shortness of breath
    • Sudden weight gain
    • Swelling of your ankles or feet

    Tell your doctor about all medications you take, including OTC medicines, vitamins, and supplements, including herbal supplements.

    Toujeo® should be taken at the same time once a day. Test your blood sugar levels daily while using insulin, including Toujeo®. Do not make changes to your dose or type of insulin without talking to your doctor. Verify that you have the correct insulin before each injection. Your dose for Toujeo® may be different from other insulins you have taken. Any change of insulin should be made cautiously and only under medical supervision.

    Do NOT dilute or mix Toujeo® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Use Toujeo® only if the solution is clear and colorless with no particles visible.

    While using Toujeo®, do not drive or operate heavy machinery until you know how Toujeo® affects you. Don’t drink alcohol or use other medicines that contain alcohol.

    The most common side effect of any insulin, including Toujeo®, is low blood sugar (hypoglycemia), which may be serious and can be life-threatening. Severe hypoglycemia may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision.

    Toujeo® may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have:

    • A rash over your whole body
    • Shortness of breath
    • Swelling of your face, tongue, or throat
    • Extreme drowsiness, dizziness, or confusion
    • Trouble breathing
    • Fast heartbeat
    • Sweating

    Toujeo® may have additional side effects including swelling, weight gain, low potassium, and injection site reactions which may include change in fat tissue, skin thickening, redness, swelling, and itching.

    Toujeo® SoloStar® is a disposable prefilled insulin pen. Talk to your doctor about proper injection technique and follow instructions in the Instruction Leaflet that comes with the pen.

    Click here for Full Prescribing Information for Toujeo®.


    Indications and Usage for Apidra® (insulin glulisine [rDNA origin] injection)

    Prescription Apidra® is for adults with type 2 diabetes or adults and children (4 years and older) with type 1 diabetes to improve blood sugar control. Apidra® given by subcutaneous injection is usually used with a longer-acting insulin. When used as a mealtime insulin, Apidra® should be given within 15 minutes before or within 20 minutes after starting a meal.

    Apidra® may be infused subcutaneously by external insulin infusion pumps.

    Important Safety Information for Apidra® (insulin glulisine [rDNA origin] injection)

    Do not use Apidra® during a low blood sugar reaction (hypoglycemia) or if you are allergic to any of the ingredients in Apidra®.

    Do not share needles, insulin pens or syringes with others. Do NOT reuse needles.

    You must test your blood sugar levels while using insulin, such as Apidra®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision. Apidra® must only be used if the solution is clear and colorless with no particles visible.

    Apidra®, when given by injection under the skin, should not be mixed with insulins other than NPH. Do not mix Apidra® with any insulin when used in the pump or for intravenous administration.

    The most common side effect of insulin, including Apidra®, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia may be serious and life threatening. It may cause harm to your heart or brain. Other possible side effects may include low blood potassium, injection site reactions, such as changes in fat tissue at the injection site, and allergic reactions, such as itching and rash. Less common, but potentially more serious or life-threatening, is generalized allergy to insulin, including anaphylactic reactions.

    Tell your doctor about other medicines, especially ones commonly called TZDs (thiazolidinediones), and supplements you are taking because they can change the way insulin works. Before starting Apidra®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed. If you have heart failure or other heart problems, it may get worse while you take TZDs with Apidra®.

    It is important to always follow the instructions provided with your Apidra® prescription for use with an external insulin infusion pump. These instructions may differ from the instructions that accompany your insulin infusion pump. Failure to follow the Apidra® specific instructions may lead to serious side effects.

    You must change the infusion set (reservoir, tubing, and catheter), and the Apidra® in the pump reservoir at least every 48 hours. Do not mix Apidra® with any insulin when used in the pump and do not dilute Apidra®.

    If the pump or infusion set does not work right or in case of handling errors, you may not get the right amount of insulin. This can cause low blood sugar (hypoglycemia), high blood sugar (hyperglycemia), high amounts of sugar and ketones in your blood (ketosis) or a build-up of acid in your blood because your body is breaking down fat instead of sugar (diabetic ketoacidosis). It is important to have another way to inject Apidra® in case the pump does not work.

    Apidra® has not been studied in children with type 2 diabetes or in children younger than 4 years of age with type 1 diabetes. In a clinical study of children with type 1 diabetes, there was a higher rate of severe symptomatic hypoglycemia in the two treatment groups (Apidra® or insulin lispro) compared to adult trials with type 1 diabetes.

    Apidra® SoloSTAR® is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

    Click here for Full Prescribing Information for Apidra®.


    What is Adlyxin™ (lixisenatide) injection?

    Adlyxin is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes, when used with diet and exercise.

    • Adlyxin is not insulin and should not be used instead of a long-acting insulin.
    • Adlyxin is not for people with type 1 diabetes or people with diabetic ketoacidosis.
    • Adlyxin has not been studied in people with a history of pancreatitis.
    • Adlyxin has not been studied in people who use short-acting insulin.
    • It is not known if Adlyxin is safe and effective in children.

    Important Safety Information for Adlyxin (lixisenatide) injection

    What is the most important information I should know about Adlyxin?

    Do not share your Adlyxin pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

    Adlyxin can cause serious side effects, including:

    • inflammation of the pancreas (pancreatitis), which may be severe and lead to death. Stop using Adlyxin and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel pain from your abdomen to your back.

    Do not use Adlyxin if you:

    • are allergic to lixisenatide or any of the other ingredients in Adlyxin.

    Symptoms of severe allergic reaction with Adlyxin may include swelling of your face, lips, tongue, or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.

    Before using Adlyxin, tell your healthcare provider if you:

    • have or have had pancreatitis, stones in your gallbladder, or a history of alcoholism.
    • have or have had kidney problems.
    • have severe problems with your stomach, such as delayed emptying of your stomach (gastroparesis) or problems with digesting food.
    • are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if Adlyxin will harm your unborn baby.

    Tell your healthcare provider about all the medicines you take, including prescription medicines (especially antibiotics and birth control pills) and over-the-counter medicines (especially acetaminophen), vitamins, herbal supplements or other medicines to treat diabetes, including sulfonylureas or insulin.

    How should I use Adlyxin?

    • Check the label on the pen each time you give your Adlyxin injection to make sure you are using the correct medication.
    • You must activate each Adlyxin pen before you use it for the first time.
    • Do not re-use or share your needles with other people. You may give other people a serious infection, or get a serious infection from them.
    • Inject your dose of Adlyxin under the skin (subcutaneously) of your abdomen, thigh, or upper arm. Do not inject into a vein.
    • Change (rotate) your injection sites within the area you chose with each dose. Do not use the same spot for each injection.

    What are the possible side effects of Adlyxin?

    Adlyxin may cause serious side effects including:

    • severe allergic reactions. Severe allergic reactions can happen with Adlyxin. Stop taking Adlyxin and get medical help right away if you have any symptoms of a severe allergic reaction.
      Talk with your healthcare provider about how to treat low blood sugar.
    • low blood sugar (hypoglycemia). Your risk for getting low blood sugar is higher if you use Adlyxin with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. The dose of your sulfonylurea or insulin medicine may need to be lowered while you use Adlyxin. Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, hunger, fast heartbeat, dizziness, confusion, irritability, sweating, and feeling jittery.
    • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse.

    The most common side effects of Adlyxin include:

    • nausea, vomiting, headache, diarrhea and feeling dizzy.

    Click here for Full Prescribing Information for Adlyxin.

    6Humalog® and 8Trulicity® are registered trademarks of Eli Lilly and Company.
    3Tresiba®, 4Levemir®, 5Novolog®, and 8Victoza® are registered trademarks of Novo Nordisk A/S.
    2Onglyza® and 9Bydurean® are registered trademarks of the AstraZeneca group of companies.
    10Tanzeum® is a registered trademark of GlaxoSmithKline.
    1Januvia® is a registered trademark of Merck & Co., Inc.